Jim Shannon – 2016 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Jim Shannon on 2016-03-01.

To ask the Secretary of State for Health, when he expects the lung cancer drug Zykadia to be available on the NHS.

George Freeman

Zykadia (ceritinib) is licensed for use in the treatment of Zykadia (ceritinib) in the United Kingdom.

The National Institute for Health and Care Excellence (NICE) is currently appraising Zykadia for previously treated anaplastic lymphoma kinase-positive non-small-cell lung cancer.

In the absence of guidance from NICE, it is for commissioners to make decisions on whether to fund new medicines based on an assessment of the available evidence.